Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Hcv-Hiv'
Hcv-Hiv published presentations and documents on DocSlides.
HCV Assays: Impact on HCV Studies
by blanko
& . Update on HCV . blood bank protocol. . Ov...
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne
by candy
Supervising Consultant: Dr K. . Rolfe. Update: Mar...
% of Global HCV Seropositive Cases
by faith
Global epidemiology of hepatitis C virus infection...
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Hepatitis C Virus HCV
by danya
Infects 30,000 people in the U.S. each year. Over...
Hepatitis C Virus HCV Infection Testing for Diagnosis31
by joanne
Con rmed Uncon rmed Uncon rmed ...
Revised 122012 HEPATITIS C VIRUS HCV Hepatitis means inflammation
by madeline
Revised 12/2012 What are the symptoms of HCV infec...
Abbott RealTime HCV Genotype II PMA CONFIDENTIAL
by desha
mHCV Genotype II Key to symbols used Global Tra...
Aptima HCV RNA Qualitative Assay
by delilah
Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
by WannabeRockstar
seroconversion. and genetically linked HCV infect...
Economic Impact of Eliminating HCV
by InLoveWithLife
H. . Razavi. April 13, 2016. HCV Economic impact m...
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
HCV 2016 Alex Rodgers Hepatologist
by radions
. FMC. Disclosures. nil. Learning objectives/. t. ...
HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community
by cheryl-pisano
HepCare Europe No-one gets left behind: address...
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
OraQuick HCV Rapid Test
by sherrill-nordquist
How to Run the . Test . Overview. Background Pres...
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Is it possible? HCV Elimination
by yoshiko-marsland
Objectives. Define elimination as it relates to i...
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]
by danika-pritchard
Strategies To Identify and Advance PWID HCV Patie...
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
HCV infection in prison. From
by olivia-moreira
individual. care to . viral. . eradication. . ...
O nline census of drug consumption rooms as a setting to address HCV:
by phoebe-click
 . current practice and future capacity.. Vendul...
HCV Screening and Linkage to Care
by alexa-scheidler
Program in a Pharmacy Setting. Conveying . the Ur...
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
by celsa-spraggs
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Housing Choice Voucher Program
by phoebe-click
LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Role of harm reduction in HCV prevention in France: from r
by tatiana-dople
Bruno Spire & Patrizia Carrieri. How to reduc...
Treatment with the second-generation HCV protease inhibitor
by conchita-marotz
Results from SILEN-C1 in HCV genotype-1 treatment...
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Hepatitis- C- Viruses
by guillermo369
NIAZY B HUSSAM. PhD. . Cinical. . Pharacy. علØ...
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
LiveR x Study Eradicating Hepatitis C in Alberta
by remy477
Cari Egan, RN, BN, MSc, PhD. LiveRx Team. Disclosu...
Load More...
![Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]](https://thumbs.docslides.com/738712/treat-to-prevent-millennials-drugs-and-hepatitis-c-hcv.jpg)
